Living with cancer: using patient perspective to accelerate oncology care
- Overall survival in RCC is improving significantly, but with this comes new considerations – for example, what should living with cancer look like, and how can we best support patients in the long term?
- Quality of life-specific endpoints must be standard in future clinical trial protocols
- Patient reported outcomes (PROs) are not regularly collected or recorded as part of routine clinical practice, despite evidence suggesting clinical benefits
- Through long-term data collation, with an increased focus on real world-data (RWD) and contribution to registries, we can develop a holistic view across cancer treatments for patient
Click here to learn more.
SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.